Impact of Intragastric Balloon Before Laparoscopic Gastric Bypass on Patients with Super Obesity: a Randomized Multicenter Study
- PMID: 27664095
- DOI: 10.1007/s11695-016-2383-x
Impact of Intragastric Balloon Before Laparoscopic Gastric Bypass on Patients with Super Obesity: a Randomized Multicenter Study
Abstract
Background: Super obese patients are recommended to lose weight before bariatric surgery. The effect of intragastric balloon (IGB)-induced weight loss before laparoscopic gastric bypass (LGBP) has not been reported. The aim of this prospective randomized multicenter study was to compare the impact of preoperative 6-month IGB with standard medical care (SMC) in LGBP patients.
Methods: Patients with BMI >45 kg/m2 selected for LGBP were included and randomized to receive either SMC or IGB. After 6 months (M6), the IGB was removed and LGBP was performed in both groups. Postoperative follow-up period was 6 months (M12). The primary endpoint was the proportion of patients requiring ICU stay >24 h; secondary criteria were weight changes, operative time, hospitalization stay, and perioperative complications.
Results: Only 115 patients were included (BMI 54.3 ± 8.7 kg/m2), of which 55 underwent IGB insertion. The proportion of patients who stayed in ICU >24 h was similar in both groups (P = 0.87). At M6, weight loss was significantly greater in the IGB group than in the SMC group (P < 0.0001). Three severe complications occurred during IGB removal. Mean operative time for LGBP was similar in both groups (P = 0.49). Five patients had 1 or more surgical complications, all in the IGB group (P = 0.02). Both groups had similar hospitalization stay (P = 0.59) and weight loss at M12 (P = 0.31).
Conclusion: IGB insertion before LGBP induced weight loss but did not improve the perioperative outcomes or affect postoperative weight loss.
Keywords: Bridge therapy; Complications; Gastric balloon; Gastric bypass; Morbid obesity.
Similar articles
-
Preoperative weight loss with intragastric balloon decreases the risk of significant adverse outcomes of laparoscopic gastric bypass in super-super obese patients.Obes Surg. 2012 May;22(5):777-82. doi: 10.1007/s11695-011-0571-2. Obes Surg. 2012. PMID: 22350986
-
Usefulness of an intra-gastric balloon before bariatric surgery.Rev Esp Enferm Dig. 2017 Apr;109(4):256-264. doi: 10.17235/reed.2017.4624/2016. Rev Esp Enferm Dig. 2017. PMID: 28229608
-
Preoperative intragastric balloon in morbid obesity is unable to decrease early postoperative morbidity of bariatric surgery (sleeve gastrectomy and gastric bypass): a clinical assay.Surg Endosc. 2020 Jun;34(6):2519-2531. doi: 10.1007/s00464-019-07061-w. Epub 2019 Aug 9. Surg Endosc. 2020. PMID: 31399943 Clinical Trial.
-
Intragastric Balloon Treatment for Obesity: Review of Recent Studies.Adv Ther. 2017 Aug;34(8):1859-1875. doi: 10.1007/s12325-017-0562-3. Epub 2017 Jul 13. Adv Ther. 2017. PMID: 28707286 Review.
-
The cost effectiveness of laparoscopic versus open gastric bypass surgery.Obes Surg. 2005 Jan;15(1):24-34. doi: 10.1381/0960892052993477. Obes Surg. 2005. PMID: 15760496 Review.
Cited by
-
Performance Characteristics of Endoscopic Sleeve Gastroplasty in Patients with Prior Intragastric Balloon: Results of a Propensity Score Matched Study.Obes Surg. 2023 Sep;33(9):2711-2717. doi: 10.1007/s11695-023-06715-y. Epub 2023 Jul 21. Obes Surg. 2023. PMID: 37474866
-
Endoscopic Bariatric and Metabolic Therapies and Their Effects on Metabolic Syndrome and Non-alcoholic Fatty Liver Disease - A Systematic Review and Meta-Analysis.Front Med (Lausanne). 2022 May 9;9:880749. doi: 10.3389/fmed.2022.880749. eCollection 2022. Front Med (Lausanne). 2022. PMID: 35615095 Free PMC article.
-
Mechanism of action and selection of endoscopic bariatric therapies for treatment of obesity.Clin Endosc. 2024 Nov;57(6):701-710. doi: 10.5946/ce.2024.005. Epub 2024 Aug 29. Clin Endosc. 2024. PMID: 39206501 Free PMC article. Review.
-
"Evaluating the Safety of the Intragastric Balloon".Obes Surg. 2024 Aug;34(8):2778-2779. doi: 10.1007/s11695-024-07396-x. Epub 2024 Jul 18. Obes Surg. 2024. PMID: 39023674 No abstract available.
-
Efficacy of Intragastric Balloon versus Liraglutide as Bridge to Surgery in Super-Obese Patients.Obes Facts. 2023;16(5):457-464. doi: 10.1159/000531459. Epub 2023 Aug 14. Obes Facts. 2023. PMID: 37579738 Free PMC article.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical